Huili Li
- Biomaterials top 5%
- Silk-based biomaterials and applications 3
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 4
-
- Extracellular vesicles in disease 5
- RNA Interference and Gene Delivery 3
-
- Liver Disease Diagnosis and Treatment 7
-
- Cardiac Fibrosis and Remodeling 5
-
- Ferroptosis and cancer prognosis 4
-
- Nanoplatforms for cancer theranostics 3
- Journals
- Nucleic Acids Research (2 papers)Nature Communications (2 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Huili Li
71 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 138
- Biomaterials 207
- Cancer Research 221
- Immunology 179
- Molecular Biology 553
- Oncology 215
Countries citing papers authored by Huili Li
This map shows the geographic impact of Huili Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huili Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huili Li more than expected).
Fields of papers citing papers by Huili Li
This network shows the impact of papers produced by Huili Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huili Li. The network helps show where Huili Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huili Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 3 | |
| 10 | 2019 | 12 | |
| 11 | 2019 | 12 | |
| 12 | 2019 | 36 | |
| 13 | 2019 | 34 | |
| 14 | 2017 | 9 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 4 | |
| 17 | 2016 | 17 | |
| 18 | 2016 | 124 | |
| 19 | Research on multi-step hydroforming of complicated thin wall circular part with small section | 2011 | 1 |
| 20 | INVOLVEMENT OF SPINAL ENDOMORPHIN 2 IN MIRROR-IMAGE PAIN INDUCED BY PERIPHERAL INFLAMMATION | 2005 | 2 |
About Huili Li
Huili Li is a scholar working on Cancer Research, Biomaterials and Cardiology and Cardiovascular Medicine, having authored 75 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Extracellular vesicles in disease (5 papers), Cardiac Fibrosis and Remodeling (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer, Lipids, and Metabolism (4 papers), RNA Interference and Gene Delivery (3 papers), Silk-based biomaterials and applications (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Biomaterials (207 citations), Cancer Research (221 citations) and Immunology (179 citations). Huili Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jiliang Wang, Jian Gu, Jianrong Guo, Zheng Wang, Lin Wang, Kun Huang, Jinxiang Zhang, Kun Huang, Xuehua Wang and Hongquan Guan. Their work appears in journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.